Glucose Injection 5% and Sodium Chloride Injection 0.9% Soft Bag 500ml-Huaren

Name: Glucose Injection 5% and Sodium Chloride Injection 0.9% Soft Bag 500ml-Huaren
Brand: Huaren Pharmaceutical Co., Ltd.
SKU: 2051106112

Shandong, ChinaHuaren Pharmaceutical Co., Ltd.

US$0.13-0.23

10,000 bottle

Sample price:US$0.00/piece.Request sample

Product profile

Customization

Available

Application

Other

Usage Mode

Intravenous Drip

Suitable for

Elderly, Children, Adult

State

Liquid

Shape

Liquid

Type

Inorganic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Drug Reg./Approval No.

H45020758

Storage

Sealed Storage

Transport Package

Carton

Specification

500ml: 25g/4.5g

Trademark

Huaren

Origin

Qingdao, Shandong, China

Production Capacity

10000000pieces/Year

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceYears of Export ExperienceExperienced Team

Huaren Pharmaceutical Co., Ltd.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 25 Years CertifiedNearest Port: Qingdao PortAverage Response Time: >24h

AI-Powered supplier vetting

SummaryThe supplier is a limited company founded in 1998, with 559 employees and a 54,736.0 m² manufacturing plant. It operates across pharmaceuticals, APIs, medical devices, medical services, medical supplies, and related production and trading activities. Evidence confirms OEM services for well-known brands, SDK availability, valid manufacturing contracts, quality assurance, raw-material traceability, and documented corrective-action and complaint-handling procedures. The supplier has an effective import/export license and reports overseas service coverage in Russia, but lacks in-stock capacity, overseas warehouses, overseas showrooms, overseas agents or branches, and offline trade-show participation. Financial information is insufficient for a credibility assessment, and no specific customer cases or formal certifications are provided.

Supplier typeThe supplier is identified as a limited company and a combined business, founded in 1998, with activities spanning pharmaceutical and health products, medical devices, manufacturing, processing, and sales. It is not identified as an offshore company and is not part of a larger company group.

After-Sales capabilityThe supplier has documented corrective and preventive action procedures, complaint-handling procedures with records, quality assurance, and raw-material traceability. It can provide overseas services in Russia, but has no overseas agents or branches, overseas warehouse, or overseas showroom, limiting local and inventory-based support.

R&D capabilityThe supplier explicitly reports R&D capability and SDK availability, and describes a strategy involving independent research and collaborative innovation. Its company profile also states that it integrates R&D, production, and sales, supporting a positive assessment of innovation capability.

Production capacityThe supplier operates a 54,736.0 m² manufacturing plant, has 559 employees, and covers pharmaceutical, API, medical-device, medical-supply, textile, and protective-product production activities. Valid manufacturing contracts exist with each related subcontractor, although the supplier reports no in-stock service capacity.

Customization capabilityOEM service for well-known brands is explicitly confirmed, indicating the ability to manufacture according to customer or brand requirements. The supplier also has documented service-capability assessment procedures and 30 qualified service suppliers, but no further details on product-development customization scope are provided.